Researchers have discovered a new biomarker for Parkinson's disease. A misfolded protein facilitates reliable diagnosis even in the early stages of Parkinson's disease in body fluids.

According to data compiled by S&P Global Market Intelligence, Kymera Therapeutics (NASDAQ: KYMR) notched an almost 23% share ...

Akeso, a Chinese biotech that made headlines for beating Merck’s Keytruda in a head-to-head trial, won approval in China this ...

A misfolded protein facilitates reliable diagnosis even in the early stages of Parkinson’s disease in body fluids.

These names in the biotech sector are seeing a substantial increase in search activity today, as determined by InvestingChannel. They include: ...

EQS-News: Pentixapharm Holding AG / Key word (s): Conference/Scientific publication Pentixapharm to Present First-in-Class Glycan-Dependent CD24 Antibody GT-008 for Solid Tumors at AACR 2025 ...

Vyne Therapeutics’ attempt to develop a safer, more tolerable BET inhibitor has hit turbulence. | Vyne Therapeutics’ attempt ...

Scientists have launched a miniature lab into Earth's orbit, which contains microbes designed to produce proteins in space.

Hans Warrinnier, chief medical officer at Bioxodes, said in a statement that the results are preliminary but all point in the ...

Nobel laureate David Baker, right, speaks with BioCentury's Simone Fishburn at the Life Science Innovation Northwest ...

– Saudi Arabia’s Food and Drug Authority (SFDA) has approved a microbial, single-cell protein called Uniprotein for use as ...